跳至主要内容
临床试验/NL-OMON51694
NL-OMON51694尚未招募不适用

Real-time Pressure volume Loop monitoring as a guide for enhanced Understanding of changes in elemental cardiovascular physiology during Therapeutic strategies aiming for hemodynamic Optimization. Cohort II: Structural heart interventions (PLUTO-II). - PLUTO-II

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 157 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
157

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Scheduled for TAVI.
  • - Scheduled for mitral TEER (Mitraclip).
  • - Scheduled for tricuspid TEER (Triclip).
  • Patients undergoing elective TAVI, mitral TEER or tricuspid TEER are eligible
  • for study participation irrespective of device specifications or device
  • manufacturer. Such technical details, (including valve size or brand), do not
  • preclude study eligibility.

排除标准

  • - Age < 18 years.
  • - Confirmed or suspected (concomitant) congenital heart disease.
  • - Mechanical circulatory support (including Impella, PulseCath, Intra-Aortic
  • Balloon Counterpulsation or Extracorporeal Membrane Oxygenation) used during
  • the procedure aiming for improved cardiac output.
  • - No (written) informed consent was obtained.

研究者

相似试验